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Background: Members of the Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) adhesion antigen
family are major contributors to the pathogenesis of P. falciparum malaria infections. The PfEMP1-encoding var
genes are among the most diverse sequences in nature, but three genes, var1, var2csa and var3 are found
conserved in most parasite genomes. The most severe forms of malaria disease are caused by parasites expressing a
subset of antigenically conserved PfEMP1 variants. Thus the ubiquitous and conserved VAR3 PfEMP1 is of particular
interest to the research field. Evidence of VAR3 expression on the infected erythrocyte surface has never been
presented, and var3 genes have been proposed to be transcribed and expressed differently from the rest of the var
gene family members.
Methods: In this study, parasites expressing VAR3 PfEMP1 were generated using anti-VAR3 antibodies and the var
transcript and PfEMP1 expression profiles of the generated parasites were investigated. The IgG reactivity by plasma
from children living in malaria-endemic Tanzania was tested to parasites and recombinant VAR3 protein. Parasites
from hospitalized children were isolated and the transcript level of var3 was investigated.
Results: Var3 is transcribed and its protein product expressed on the surface of infected erythrocytes. The VAR3-expressing
parasites were better recognized by children´s IgG than a parasite line expressing a Group B var gene. Two in 130 children
showed increased recognition of parasites expressing VAR3 and to the recombinant VAR3 protein after a malaria episode
and the isolated parasites showed high levels of var3 transcripts.
Conclusions: Collectively, the presented data suggest that var3 is transcribed and its protein product expressed on the
surface of infected erythrocytes in the same manner as seen for other var genes both in vitro and in vivo. Only very few
children exhibit seroconversion to VAR3 following a malaria episode requiring hospitalization, supporting the previous
conclusion drawn from var3 transcript analysis of parasites collected from children hospitalized with malaria, that VAR3 is
not associated with severe anaemia or cerebral malaria syndromes in children.Background
Plasmodium falciparum is a major cause of mortality
and disease in sub-Saharan Africa. Immunity to malaria
in areas with intense transmission is acquired during
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medium, provided the original work is properantigens present on the infected erythrocyte surface,
develops [1-3]. Plasmodium falciparum erythrocyte
membrane protein 1 (PfEMP1) is the best characterized
variant surface antigen [4-6]. A single parasite express
only one or a few variants at a time [7-11] as the parasite
develops from ring-shaped early forms into trophozoite
stages, simultaneously with the onset of adhesion and
antigenicity of the infected erythrocyte [12]. Members of
the PfEMP1 family mediate the cyto-adherence of
infected erythrocytes to host receptors, allowing parasites
to avoid splenic clearance and an immense sequence
variation within the protein family has evolved to escapetd. This is an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any
ly cited.
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PfEMP1 family is encoded by approximately 60 var
genes per parasite genome [6,15], which can be divided
in two four groups A-E based on their 5´upstream region
[16,17]. Three var genes, var1 (UPSA), var2csa (USPE),
and var3 (aka Type 3) (UPSA) are conserved in their full
length in the global parasite population [18-22]. Apart
from these, most parasite genomes contain a set of vars
encoding more diverse domain cassettes not spanning the
full length genes [23]. PfEMP1s are composed of multiple
Duffy binding-like (DBL) and cysteine-rich inter-domain
region (CIDR) domains. Among the PfEMP1s the VAR1,
VAR2CSA and VAR3 variants have unique domain com-
positions void of CIDR domains. While VAR1 is particu-
larly, long consisting of seven DBL domains and one
CIDR, VAR3 and VAR2CSA distinguishes themselves by
not containing any CIDR domains. In addition VAR3 is
the smallest of the PfEMP1 proteins [15] and is the only
PfEMP1 consisting of only two domains; DBLα/ζ and
DBLε [23]. Var3 genes have arisen from a recombination
between a DBLζ-DBLε encoding sequence only found in
the 3´end of var exon1 and an N-terminal DBLα1 se-
quence. Sequence analysis has shown that only the DBLζ-
DBLε part of VAR3, which is 99% identical between VAR3
sequences, is unique to the protein sub-family [23].
VAR2CSA binds chondroitin sulphate A (CSA) in the
placenta and facilitates the parasite sequestration causing
pregnancy-associated malaria. Similarly, organ specific
PfEMP1 mediated sequestration has been linked to severe
malaria in children [24], and evidence indicates that a
restricted and antigenically conserved subset of variant
surface antigens causes the most severe malaria syndromes
in children [25-32]. Thus, it is hypothesized that defined
PfEMP1 subtypes confer specific adhesion phenotypes for
the parasites [23]. Several studies have aimed to identify
the var types expressed in severe malaria [29,30,33-36].
Most of these have relied on defining the most prevalent
var mRNA species by PCR amplification and sequencing
of a short 350 bp DBLα tag present in all var genes except
var2csa and var3. As this approach does not capture var3
sequences, quantitative PCR has been deployed to investi-
gate var3 transcript levels in patient samples [29,37]. The
overall conclusion from these studies is that members of
the UPSA var genes are associated with severe malaria in
children.
Because VAR3 is conserved, belongs to group A
PfEMP1 and has an unusual domain structure, this pro-
tein could play a particular important role for the para-
site and in development of malaria disease. Malaria-
endemic populations has been shown to have acquired
antibodies that react with recombinant VAR3 protein [38],
suggesting that the protein is expressed and immunogenic
during natural infections. However, quantitative PCR stud-
ies of var3 transcript levels in malaria patient samples haveshown that var3 transcripts was not associated to any par-
ticular syndrome of severe malaria [37]. A formal demon-
stration of VAR3 on the surface of P. falciparum-infected
erythrocytes has never been achieved and evidence pre-
sented by Epp et al. [39] suggests that var3 transcription
may be regulated differently from the rest of the var genes
and expressed in a non-mutually exclusive manner due to
an atypical intron activity.
In an effort to unravel some of the mystery surrounding
this PfEMP1, parasites of different genetic background
were successfully manipulated to express VAR3 on the sur-
face of the infected erythrocytes. Analysis of these parasites
suggests that both var3 mRNA and VAR3 protein is
expressed similar to other PfEMP1s. Furthermore, in this
study, evidence for in vivo expression of VAR3 in malaria-
sick children is presented.
Methods
Parasite culture, in vitro selection and synchronization
Plasmodium falciparum clones 3D7 and IT/FCR3 para-
sites were cultured in O Rh + erythrocytes in RPMI1640
supplemented with Albumax II, as previously described
[40]. Parasites were synchronized by magnet-activated cell
sorting (MACS; Miltenyi BioTec) and 24 h later ring stage
parasites were harvested for RNA-extraction. The develop-
mental stage of parasites was confirmed by assessment of
500 erythrocytes on Giemsa-stained thin smears. Parasite
cultures were centrifuged and 1 ml Trizol (Invitrogen) was
added to the pellet to preserve RNA. 3D7 and IT/FCR3
parasites were selected as previously described [41] by
repeated rounds of panning on DynaBeads coated with
rabbit IgG specific for the 3D7 VAR3 double domain of
PFI1820w. A more stringent synchronization of the
3D7VAR3 line was done by gelatine purification of late-
stage trophozoites and schizonts and further enriched 48 h
later on a MACS column. The synchronous population
of parasites was cultured in six different culture flasks
and harvested at six different time points of the intra-
erythrocytic life cycle. The developmental stages of the
3D7VAR3 parasites at the six time points were deter-
mined by assessment of 900 erythrocytes on thin
smears stained by Giemsa.
Isolate integrity of the cultures was tested using the
method previously described by Snounou et al. [42] with
the following modifications: only the second round of
amplification was done using the MSP2-IC1, MSP2-
FC27 and GLURP specific primer pairs. The conditions
of the PCR were as follows for all three reactions: 94°C
for 15 min, 35 cycles of 94°C for 1 min, 61°C for 2 min
and 65°C for 2 min, followed by 58°C for 2 min and 65°C
for 5 min. The PCR reaction contained: 0.125 μM of the
primer pairs, 1:1 of TEMPase Hot Start DNA Polymer-
ase (Ampliqon, VWR) and 1 μL of DNA extracted using
the DNeasy Kit (Qiagen) according to the manufacturer’s
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boratory isolates (3D7, IT/FCR3, DD2, K1, and HB3) as
well as P. falciparum negative controls, human DNA
from Danish donors and blank samples, were included in
the setup and the amplified PCR products were analysed
by agarose gel electrophoresis.
RNA extraction and cDNA synthesis
RNA was extracted using Trizol (Invitrogen) according
to manufacturer’s instructions. Samples were treated
with DNase I (Sigma) to digest any genomic DNA and
tested in quantitative PCR for contamination, using a
primer set, p90, for the seryl-tRNA synthetase gene. RNA
was reverse transcribed from random hexamers, using
Superscript II (Invitrogen), according to the manufac-
turer’s instructions (Invitrogen).
Primer design
Quantitative primers for each var gene of the P. falciparum
clone 3D7 and to the endogenous control genes seryl-
tRNA synthetase and fructose-bisphosphate aldolase, have
been described previously [20] with modifications [43].
Specific quantitative primers were designed for 56 var
genes extracted from the IT/FCR3 genome available
at The Wellcome Trust Sanger Institute (UK) [44]
(Additional file 1). The primers were validated by
testing amplification efficiency relative to p90 on 10-
fold dilutions of genomic DNA using quantitative
PCR. All primer pairs had amplification efficiencies
>90%, and produced single band products on agarose
gel electrophoresis with single melting peaks in melt-
ing curve analysis. Two cross-intron primers to de-
tect spliced PFI1820w/PFF0020c/IT4var3 (var3Xi) and
PFA0015c (PFA0015cXi) transcripts, respectively, were
designed as well (Additional file 1). The amplification
efficiency of these primers was not determined; how-
ever, their correct PCR amplification product sizes
from genomic DNA and cDNA of both 3D7 and IT/FCR3
parasites was confirmed on agarose gel electrophoresis. A
primer pair designed to universally amplify var3 transcripts
was also used (Additional file 1). To further validate the
specificity of all primers, the PCR products were
sequenced, using the specific forward and reverse primer.
All primer pairs were specific for their target genes.
Quantitative PCR
Quantitative PCR was performed on a Rotorgene RG-3000
thermal cycler (Corbett Research), applying QuantiTect
SYBR Green PCR Master Mix (Qiagen) with primers at
20 μM, and internal control genes seryl-tRNA synthetase
and fructose-bisphosphate aldolase, used for normalization.
Gene-specific standard curves were produced by determin-
ing the amplification efficiency relative to the single copy
internal control gene, seryl-tRNA synthetase, based onquantitative measurements of 10-fold dilutions of genomic
DNA and used to calculate the transcript copy number of
each gene in tested cDNA. Transcript levels relative to the
average level of the two internal control genes were calcu-
lated as 2-ΔCt(var gene) and the level of internal control genes
were set to 100 (User Bulletin #2: ABI Prism 7700 Se-
quence Detection System; Applied Biosystems)
Protein expression and generation of antiserum
Protein expression was performed as previously
described [28,46] and the rabbit antiserum raised against
recombinant DBLα-DBLε double domain (~90 kDa) of
the clone 3D7 PFI1820w protein from a previous study
[38] was used in this present study. The antiserum was
tested positive in ELISA for reactivity against the im-
munizing antigen [38]. Depletion of antibodies reacting
with erythrocyte antigens was done by mixing equal
amounts of antiserum with human O+ erythrocytes and
incubating 24 h at 4°C. Besides the full length VAR3 pro-
tein, two full length and four multi-domain PfEMP1 pro-
teins were included in the Luminex assay (Additional file
2). The C-terminal region of MSP3 was included as con-
trol as previously described [48].
Flow cytometry
The surface expression of VAR3 PfEMP1 by 3D7VAR3
and FCR3VAR3 lines was assessed by flow cytometry [49].
The erythrocyte surface antigen phenotype of line
FCR3VAR3 was characterized using plasma from 61 chil-
dren (from age one to 19 years) living in Mgome, Tanzania
(an area of holo-endemic malaria transmission), from a
cross-sectional survey [50], for IgG surface-staining of
infected erythrocytes. Danish plasma was used as a control.
Acute and convalescent plasma from 130 under five-year-
old children living in north-eastern Tanzania experiencing
a malaria episode was also tested with the FCR3VAR3 line.
Informed consent forms were signed by parent or legal
guardians of all subjects and the trials were reviewed and
approved by the Medical Research Coordinating Commit-
tee, Tanzania (NIMR/HQ/R.8a/Vol.IX/559). The data was
acquired using a FC500 instrument (Beckman Coulter).
Uninfected erythrocytes were analysed to exclude IgG
binding to erythrocyte antigens.
Confocal microscopy
Indirect immuno-fluorescence assays were performed on
live 3D7VAR3/3D7 unselected and FCR3VAR3/IT/FCR3
unselected in order to observe the staining of individual
infected erythrocytes with VAR3-antibodies. The staining
was done using AlexaTM488 anti-rabbit IgG (Invitrogen)
and DAPI and laser scanning confocal microscopy per-
formed using a Nikon TE 2000-E confocal microscope
with 60x oil immersion objective lens (DIC) as previously
described [51].
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Levels of plasma PfEMP1 domain-specific IgG were ana-
lysed as described previously [52]. In brief, lyophilized
microspheres were reconstituted with distilled water im-
mediately prior to use and diluted 1:333 in assay buffer E
(ABE; 0.1% bovine serum albumin [BSA], 0.05% Tween
20, and 0.05% sodium azide in PBS, pH 7.4). Aliquots
(50 μl) were dispensed into the wells of 1.2-μm filter-bottom
96-well microtitre plates (MSBVS 1210; Millipore) pre-
wetted with ABE and washed three times with ABE by
using a vacuum manifold (Millipore). Frozen plasma sam-
ples were thawed at room temperature, mixed by vortexing,
and spun (16,000 × g for 5 min) to remove particulates.
Plasma samples were diluted 1:80 in ABE and 50-μl aliquots
were added to the microsphere wells. After incubation in
the dark on a shaking platform (30 sec at 1,100 rpm fol-
lowed by 30 min at 300 rpm), the plates were washed three
times in ABE to remove unbound antibody. Biotinylated
anti-human IgG (Sigma) antibody (25 μl/well at 1:500 dilu-
tion) was added to the microspheres, which were incubated
and washed as described above. This was followed by use of
streptavidin-phycoerythrin (Sigma) (50 μl/well at 1:500), in-
cubation in the dark with shaking (30 sec at 1,100 rpm fol-
lowed by 10 min at 300 rpm), and washing as described
above. Finally, the microspheres were resuspended in 125 μl
of ABE and analysed on a Luminex 100 IS instrument set to
read a minimum of 100 microspheres per microsphere re-
gion. Antibody levels for each domain were expressed as
median fluorescence intensities (MFI). A negative cut-off
value of 249 MFI units, based on the reactivity measured in
plasma from unexposed control donors was used.
Results
Generation of VAR3 expressing 3D7 and IT/FCR3 parasite
lines
To generate in vitro model parasite lines expressing VAR3,
parasites of two laboratory cultured parasite clones, 3D7
and IT/FCR3, were selected with rabbit antiserum against a
3D7 VAR3 (PFI1820w) recombinant protein. The expression
of VAR3 on the surface of 3D7VAR3- and FCR3VAR3-
infected erythrocytes, respectively, was investigated by flow
cytometry and confocal microscopy using rabbit IgG specific
for the clone 3D7 VAR3 PFI1820w which they had been
selected with. The selected lines, 3D7VAR3 and FCR3VAR3,
were recognized by the rabbit serum and stained the
infected erythrocytes in a punctuate pattern typical for
PfEMP1 [11,51] whereas the unselected lines were not
recognized (Figure 1). Non-immune rabbit IgG did not stain
the infected erythrocytes.
VAR3 expressing parasite lines exhibit transcript patterns
similar to other var gene expressing parasites
The var transcript profiles of the selected 3D7VAR3 and
FCR3VAR3 and unselected 3D7 and IT/FCR3 parasitelines were investigated using var gene specific primers in
quantitative PCR. The transcript levels of all var genes
relative to internal control genes are shown in Figure 2.
The selected lines, 3D7VAR3 and FCR3VAR3, showed
markedly higher levels of var3 transcripts, PFI1820w and
IT4var3, than the unselected lines and the var3 tran-
script levels were similar to those observed for var genes
in vivo [53] and other adhesion-selected in-vitro parasite
cultures with verified erythrocyte surface expression of
PfEMP1 [20,28]. Interestingly, antibody selection of 3D7,
which harbour three var3 genes, resulted in selection of
parasites expressing two of these genes (PFI1820w and
PFF0020c) but not parasites expressing the third
(PFA0015c) (Figure 2a). A specific cross-intron primer
pair confirmed the correct splicing of var3 transcripts
(Table 1). To investigate whether the pattern of var3
transcription diverge from that of other var genes, the
3D7VAR3 line was synchronized and RNA isolated
throughout the intra-erythrocytic asexual lifecycle. The
two var3 genes, PFI1820w and PFF0020c, were the dom-
inant var transcripts during the entire cycle with the ex-
ception at 0 h post MACS (PM), with a peak in
transcript level at 19 h PM corresponding to mid ring
stages (Figure 3) and thus exhibits a transcription pattern
similar to var2csa in a VAR2CSA-expressing parasite line
[43] and four group A var genes in the 3D7-Lib parasite
line [45].
Serorecognition of 61 plasma samples from Mgome of
FCR3VAR3
The IgG reactivity to live FCR3VAR3 parasites in plasma
from 61 individuals between one and 19 years of age liv-
ing in a high transmission village of Mgome, Muheza
Tanzania, was evaluated by flow cytometry (Figure 4).
The 61 individuals were split into five different age
groups (one to three, three to five, five to 10, 10 to 15,
15 to 19) and eight Danish donors were used as controls.
The level of reactivity was compared to that of parasites
expressing a Group A var gene, IT4var60, thought to
mediate rosetting [54] and parasites expressing a Group
B var gene, IT4var59 (Additional file 3). The domain
structures of the three expressed PfEMP1 proteins are
shown as well (Figure 4). The FCR3VAR3 parasites were
recognized by similar levels of IgG in children’s plasma
as the parasites expressing IT4var60 and by higher levels
of IgG than the parasites expressing group B IT4var59
(Figure 4). For the var3 and IT4var60 expressing parasite
lines the <3 year olds showed the lowest IgG level but
the level rose to a plateau already at the age of 3 to
<5 years old. All 61 children had higher IgG levels
against these two parasite lines than the Danish control
donors. In contrast, the IT4var59 parasite line was only
recognized by a few of the Mgome plasma donors with a
peak in the group of 10 to 15 year olds.
Figure 1 VAR3 on the surface of Plasmodium falciparum infected erythrocytes. Reactivity with anti-VAR3 antibodies of live P. falciparum 3D7
and IT/FCR3 before and after antibody selection with a rabbit antiserum against recombinant DBLα/ζ-DBLε of PFI1820w shown as (a) number of
events/P. falciparum-infected erythrocytes vs. FITC flourescence intensity by flow cytometry, (b) DIC shadow-cast image with the fluorescence
image superimposed and (c) the fluorescence image alone on serorepresentative infected erythrocytes in confocal microscopy. Scale bar 5 μM.
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isolates
The IgG reactivity to the FCR3VAR3 parasite line and re-
combinant VAR3 protein was investigated in acute and
convalescent plasma from 130 children under five years of
age from high malaria transmission villages of Korogwe,
Tanzania, experiencing a malaria episode. Antibodies to
FCR3VAR3 was observed in 15 (11%) of the acute patient
plasma samples. Only two boys, patient A and B, appeared
to acquire IgG to VAR3 but not to VAR2CSA expressing
parasites after being sick and hospitalized with malaria
(Figure 5a and b). An increased level of VAR3 IgG in pa-
tient A and B convalescent plasma was also found by lumi-
nex assay assessment of IgG levels to recombinant full
length VAR3 and a panel of six different multi-domain and
full length PfEMP1 proteins (Figure 5c and d). Patient A
and B were hospitalized in north-eastern Tanzania at the
age of 22/3 and 5 years old with body temperatures of 39.5°
C and 39.8°C, parasitaemias of 266,735 and 159,470 para-
sites/μL, Blantyre Coma Scores of 5, lactate levels of
3 mM, and haemoglobin values of 8.6 and 10.8 g/dl, re-
spectively. Patient B appeared to have a broader anti-
PfEMP1 IgG repertoire than patient A, which could be
due to a difference in exposure as patient B is almost twice
the age of patient A. Total RNA from the infecting para-
sites was isolated and the level of var3 transcripts was
investigated using universal and 3D7 and IT/FCR3 var3
specific primers in quantitative PCR. The var3 transcript
levels in these samples were lower than in the VAR3-
selected laboratory parasite lines (Table 1), but at levels
previously considered high in var transcript analyses of
field samples (Additional file 4). The transcript levels of
other var genes in the samples were assessed using a
set of 42 var subtyping quantitative PCR primers [37]
(Additional file 4). These data indicates that apart from
var3, other group A and DC8 encoding var genes are
expressed at high levels in the two patients.Discussion
The PfEMP1 mediated parasite sequestration causes
harmful inflammation and severe pathology of malaria
disease and evidence suggests that particular PfEMP1 sub-
types are associated with different syndromes of malaria
(reviewed in [55]). In pregnant women, malaria is caused
by VAR2CSA mediated parasite sequestration in the pla-
centa [53] and the subgroup of UPSA flanked var genes
which includes the conserved var3 variant has been asso-
ciated with severe malaria in children [28-32]. The particu-
lar involvement of VAR2CSA in pregnancy malaria and
the ubiquitous and conserved nature of VAR2CSA make it
an apparent vaccine target. The same might apply for
VAR3, but no particular function has been ascribed to
VAR3 and analysis of var3 transcripts in patient isolates
[29,37] does not predict a particular association with se-
vere malarial disease in children. Nevertheless, the data
presented in this paper indicate that VAR3 expressing
parasites are viable in vivo and can bestow significant
proportions of parasite populations in children sick
from malaria. Specifically, IgG from children down to
the age of one year reacted with VAR3 PfEMP1-
expressing parasites where the level of recognition
seemed to increase with age and find a plateau within
the first three years of age. The VAR3-expressing para-
sites were better recognized by the children´s IgG than
a parasite line expressing a Group B var gene. Although
VAR3 is less polymorphic than Group B PfEMP1s, these
data may indicate an earlier exposure to VAR3-expressing
parasites than to Group B PfEMP1-expressing parasites,
suggesting a particular involvement in early childhood
malaria as predicted for the UPSA type PfEMP1 in general
[17,28-30]. Of the 130 acute-convalescent samples from
children under five years of age, only two children were
found to acquire IgG antibodies to VAR3 as a result of an
acute malaria episode requiring hospitalization. Patient A
suffered from hyperparasitaemia but neither of the two
Figure 2 Var gene transcript levels in VAR3-expressing Plasmodium falciparum parasites. Var gene transcript levels relative to the average
of two internal control genes before and after antibody selection of P. falciparum (a) 3D7 and (b) IT/FCR3 parasites, using Dynabeads coated with
rabbit IgG specific for VAR3 PfEMP1. The average of control gene transcript levels is set to 100. The distribution of var transcripts before and after
selection is also shown (circular diagrams). Transcript levels were measured by quantitative PCR using a set of primers that amplify 59 and 56 var
genes from clone 3D7 and IT/FCR3, respectively. A cross-intron primer specific for the clone 3D7 var3 genes, PFI1820w and PFF0020c, and the
clone IT/FCR3 var3 gene, IT4var03, showed similar transcript level as the corresponding exon 1 primer pairs (Table 1). The grouping of var genes
are as previously described [16,17,23].
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Parasites isolated at hospitalization were found to tran-
scribe var3-like genes at high levels, which together with
the acquired antibodies indicate that VAR3-expressing
parasites have contributed to the development of malaria
symptoms in these patients. However, other var typetranscripts were also detected in these patients and thus
the VAR3-expressing parasites did not appear to be the
only cause of disease in these two patients.
The pattern of Tanzanian children´s acquisition of
antibodies to live VAR3-expressing parasites compared
to UPSA and UPSB type PfEMP1-expressing parasites
Table 1 The RNA levels of var3 in patient A and B parasite isolates and four laboratory parasite lines
Sample Primer pair Patient A Patient B 3D7 VAR3 FCR3 VAR3 FCR3 IT4var60 FCR3 IT4var59
DBLε8 (var3Global) 187.6 419.9 1837.9 701.3 0.9 0.3
PFI1820w (3D7) ND ND 1055.6 ND ND ND
PFF0020w (3D7) ND ND 807.8 ND ND ND
PFA0015c (3D7) ND ND 17.7 ND ND ND
IT4var3 (FCR3) ND ND ND 696.4 0.3 0.1
VAR3Xi (3D7 and FCR3) ND ND 1492.9 621.2 0.7 0.0
PFA0015cXi (3D7) ND ND 17.7 0.0 0.0 0.0
RNA level is shown relatively to an average RNA level of the housekeeping genes, seryl-tRNA synthetase and fructose-bisphosphate aldolase, set to 100.
ND: Not done.
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PfEMP1. Yet, in spite of the conserved nature of var3
and the presence in almost every parasite genome, it
is striking that only a fifth of 1,342 individuals from
malaria-endemic areas in Tanzania showed acquisition
of antibodies to this PfEMP1 [38]. This may reflect ei-
ther that VAR3 is not very immunogenic and/or para-
sites expressing VAR3 are not very virulent as also
suggested by QPCR studies [29,37] and the acute/con-
valescent plasma study described here.
These interpretations of var3 transcribing parasites
and VAR3 antibodies in malaria patients can be chal-
lenged if var3 genes are regulated and expressed abnor-
mally as appears to be the case for var1. Studies of
laboratory parasite lines show that var1 is constitutively
transcribed throughout the blood stages cycle, while the
transcription of other var genes is silenced when para-
sites develop into schizonts [56]. In spite of this and the
fact that malaria endemic populations develop anti-Figure 3 Transcript levels of 59 var genes during the intra-erythrocyt
measured by quantitative PCR and shown as amplification efficiency correc
most prominent transcript levels are shown. LS: Late stages; ER: Early Ring;
S: Schizont. hPM: h post magnet-activated cell sorting.VAR1 antibodies [38], VAR1 erythrocyte surface expres-
sion has not been demonstrated. Analysis of available
sequenced parasite genome shows that var1 often lacks
or has a truncated exon2 which may cause a corrupted
transcription regulation resulting in protein synthesis
and host antibody development upon parasite destruc-
tion. It remains unclear if VAR1 serves a particular func-
tion for the parasite and why var1 is maintained in the
population. Indeed, Epp and colleagues [39] found that
the atypical var intron of the PFF0020c var3 gene did
not show any transcriptional activity as opposed to other
non-VAR3 var introns. Non-coding RNA is transcribed
from var introns and is physically associated with chro-
matin and believed to be involved in the transcriptional
regulation of var genes [39]. Thus, it was speculated that
var3 genes in general could be regulated differently from
other var genes. From the present data it does not seem
that var3 genes are transcribed and expressed differently
from other var genes. In both 3D7VAR3 and FCR3VAR3ic life cycle of parasite line 3D7VAR3. Transcript levels were
ted ΔCt-values relative to internal control genes. Annotations of the
MR: Mid Ring; LR: Late Ring; ET: Early Trophozoite; LT: Late Trophozoite;
Figure 4 Immune serum reactivity to three IT/FCR3 Plasmodium falciparum parasite lines. The reactivity of 61 plasma samples from
children living in malaria endemic Mgome, Tanzania, against three parasite lines expressing VAR3 (Group A PfEMP1), IT4var60 (Group A PfEMP1)
and IT4var59 (Group B PfEMP1), respectively, was measured by flow cytometry and divided into age groups: [1- <3] n = 4; [3- <5] n = 6; [5- <10]
n = 23; [10- <15] n = 19; [15- <19] n = 9. Danish controls n = 8. The PfEMP1 domain structures as previously described [23] are shown below each
parasite seroprofile. Ends of whiskers in the boxplots represent the smallest and largest median of FITC fluorescence intensity (MFI) values in the
given age group.
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transcript profile during the intra-erythrocytic life cycle
was similar to that of other var genes in other parasite
lines [43,52] and predicts as expected the surface expres-
sion of VAR3 in early trophozoite stages.Figure 5 Reactivity to VAR3-expressing Plasmodium falciparum parasites
lines IT/FCR3 expressing VAR3 and VAR2CSA (a, b) and recombinant proteins (c,
(acute, grey shades) and after recovery (convalescent, red lines). The reactivity is
flourescence intensity by flow cytometry. The acquisition of IgG to seven multi-d
falciparum was measured by bead-based Luminex technology as previously des
subtracted the reactivity of unexposed control donors. The PfEMP1 domains repAlso the VAR3 expression on the erythrocyte surface
appeared similar to that of other PfEMP1. Antibodies
raised towards a recombinant 3D7 VAR3 variant suc-
cessfully selected VAR3 erythrocyte surface-expressing
parasites from both 3D7 and IT/FCR3 parasiteafter a malaria episode. The recognition of two P. falciparum parasite
d) with plasma from patient A (a, c) and B (b, d) during a malaria episode
shown as number of events/P. falciparum-infected erythrocytes vs. FITC
omain and full length (FL) PfEMP1 proteins and MSP3 antigen of P.
cribed [48]. Results are expressed as median fluorescent intensity (MFI)
resenting domain cassette (DC) 5, 6 and 7 are as defined by Rask et al. [23].
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http://www.malariajournal.com/content/11/1/129populations. The surface expression of VAR3 was con-
firmed by antibody staining in both flow cytometry and
confocal microscopy with expression levels and a punc-
tuate pattern characteristic for PfEMP1 expression in
knobs. While the VAR3 in the IT/FCR3 line most likely
is the only PfEMP1 on the infected erythrocyte surface,
it is possible that both PFI1820w and PFF0020c VAR3
PfEMP1s are expressed by the same parasites, as previ-
ously seen in 3D7 parasites [11].Conclusions
In conclusion, var3 is transcribed and the encoded protein
expressed on the surface of infected erythrocytes in the
same manner as seen for other viable var genes. VAR3-
expressing parasites sustain P. falciparum infections in
children living in malaria-endemic areas although only
found in a fraction of malaria hospitalizations and not asso-
ciated with severe anaemia or cerebral malaria syndromes.
Whether this structurally unique and conserved PfEMP1
confer parasites expressing it with a rare functional
specialization remains unclear, but further studies of
the cyto-adherence phenotype of the established VAR3-
expressing parasite lines may elucidate this.Additional filesAdditional file 1: Specific var gene primers used for Q-RT PCR.
Additional file 2: Primers used for Plasmodium falciparum
erythrocyte protein 1 full length (FL) and multi-domain expression.
Additional file 3: Var gene transcript levels of Plasmodium
falciparum IT4var59 parasites. Var gene transcript levels of IT4var59
parasites relative to the average of two internal control genes. The
average of control gene transcript levels is set to 100. The distribution of
var transcripts is also shown (circular diagram). Transcript levels were
measured by quantitative PCR using a set of primers that amplify 56 var
genes from clone IT/FCR3. The grouping of var genes are as previously
described [16,17,23].
Additional file 4: Transcript levels of var3 in patient parasite
isolates. Transcript levels of var3-DBLε8 in P. falciparum parasites isolated
from 130 hospitalized children (little box; red dots: patient A and B) and
the var subtype transcript levels in patient parasite isolates, A and B. The
levels are relative to the average of two internal control genes, which are
normalized to 100. Transcript levels were measured by quantitative PCR
using a set of 42 subtyping quantitative primers [37].Competing interests
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